| Literature DB >> 26279205 |
Manfred Fliegauf1, Vanessa L Bryant2, Natalie Frede1, Charlotte Slade3, See-Tarn Woon4, Klaus Lehnert5, Sandra Winzer1, Alla Bulashevska1, Thomas Scerri2, Euphemia Leung6, Anthony Jordan7, Baerbel Keller1, Esther de Vries8, Hongzhi Cao9, Fang Yang9, Alejandro A Schäffer10, Klaus Warnatz1, Peter Browett6, Jo Douglass11, Rohan V Ameratunga4, Jos W M van der Meer12, Bodo Grimbacher13.
Abstract
Common variable immunodeficiency (CVID), characterized by recurrent infections, is the most prevalent symptomatic antibody deficiency. In ∼90% of CVID-affected individuals, no genetic cause of the disease has been identified. In a Dutch-Australian CVID-affected family, we identified a NFKB1 heterozygous splice-donor-site mutation (c.730+4A>G), causing in-frame skipping of exon 8. NFKB1 encodes the transcription-factor precursor p105, which is processed to p50 (canonical NF-κB pathway). The altered protein bearing an internal deletion (p.Asp191_Lys244delinsGlu; p105ΔEx8) is degraded, but is not processed to p50ΔEx8. Altered NF-κB1 proteins were also undetectable in a German CVID-affected family with a heterozygous in-frame exon 9 skipping mutation (c.835+2T>G) and in a CVID-affected family from New Zealand with a heterozygous frameshift mutation (c.465dupA) in exon 7. Given that residual p105 and p50—translated from the non-mutated alleles—were normal, and altered p50 proteins were absent, we conclude that the CVID phenotype in these families is caused by NF-κB1 p50 haploinsufficiency.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26279205 PMCID: PMC4564940 DOI: 10.1016/j.ajhg.2015.07.008
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025